High lipoprotein(a) levels and small apolipoprotein(a) sizes are associated with endothelial dysfunction in a multiethnic cohort  by Wu, Henry D. et al.
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OBJECTIVES This study sought to determine the effect of lipoprotein(a), or Lp(a), levels and apolipopro-
tein(a), or apo(a), sizes on endothelial function and to explore ethnic differences in their
effects.
BACKGROUND Although high levels of Lp(a) have been shown to confer increased cardiovascular risk in
Caucasians, its significance in non-Caucasian populations is uncertain. The pathogenic role
of the apo(a) component of Lp(a) is also unclear.
METHODS The relationship of Lp(a) levels and apo(a) sizes to endothelial function was examined in a
multiethnic cohort of 89 healthy subjects (age 42 9 years; 50 men, 39 women) free of other
cardiac risk factors. Endothelium-dependent, flow-mediated dilation (FMD) and
endothelium-independent, nitrate-induced dilation (NTG) were assessed by ultrasound
imaging of the brachial artery.
RESULTS Plasma Lp(a) levels were lowest in Caucasians (18.3  21.1 mg/dl, n  40); intermediate in
Hispanics (30.2  30.5 mg/dl, n  21); and highest in African Americans (68.8  46.0
mg/dl, n  28). Lipoprotein(a) levels were found to correlate inversely to FMD (r  0.33,
p  0.005) but not to NTG (r  0.06, p  0.60). This association remained significant after
adjusting for gender (p  0.002). In addition, subjects with small apo(a) size of 22 kringle
4 repeats had significantly lower FMD than those with large apo(a) (2.23  2.37% vs. 6.26
 4.29%, p  0.0001), irrespective of Lp(a) levels.
CONCLUSIONS These findings support an independent role of Lp(a) in atherogenesis, an effect that is
particularly evident in African Americans. The proatherogenic property of Lp(a) can be
attributed in part to its apo(a) component. (J Am Coll Cardiol 2004;43:1828–33) © 2004
by the American College of Cardiology Foundationf
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dipoprotein(a), or Lp(a), is composed of a cholesterol-rich
article linked to a glycoprotein of variable size called
polipoprotein(a), or apo(a). High levels of Lp(a) have been
hown to be a risk factor for cardiovascular disease (1).
pidemiologic studies conducted in Caucasian populations
ound Lp(a) levels of above 30 mg/dl to increase risk by a
actor of two to three. However, recent prospective studies
ave not been entirely consistent in this regard (2–4).
oreover, a similar risk association was not observed in
frican Americans (5,6). This latter observation is particu-
arly puzzling given that African Americans tend to have
igher Lp(a) levels than Caucasians (7). Because of these
nconsistencies, the pathogenic role of Lp(a) remains un-
ertain.
The Lp(a) level is determined primarily by the apo(a)
ene, which varies in size according to the copies of kringle
(K4) domains. In Caucasians, Lp(a) levels correlate
egatively with apo(a) size, and K4 of22 copies have been
hown to be associated with coronary artery disease (8–10).
n the other hand, Lp(a) levels tend to correlate less closely
ith apo(a) sizes in African Americans (11,12). This dif-
From the Department of Medicine, Columbia University, New York, New York.
upported by a Clinical Associate Physician Award from the NIH (M01 RR00645)
nd a Pilot Grant from Columbia University to Dr. Wu and an NIH grant (HL
2705) to Dr. Berglund.
Manuscript received March 3, 2003; revised manuscript received August 8, 2003,sccepted August 18, 2003.erence in size/level correlation among ethnic groups allows
or a unique opportunity to delineate the relative contribu-
ion of these factors to the atherogenic process.
Accordingly, this study assessed the relationship of Lp(a)
evels and apo(a) sizes to endothelial function in a multi-
thnic cohort free of traditional cardiac risk factors. Endo-
helial dysfunction is an early and crucial event in athero-
enesis (13). Endothelium-dependent flow-mediated
ilation (FMD) of the brachial artery has been demon-
trated to be impaired in asymptomatic subjects with various
stablished risk factors including those with hypercholester-
lemia (14,15). Because endothelial dysfunction occurs at a
reclinical stage of disease, its presence serves as a highly
ensitive disease marker that may help clarify the pathogenic
ole of Lp(a) and apo(a) in various ethnic groups.
ETHODS
tudy population. Healthy volunteers were randomly re-
ruited by poster advertisement from the community served
y Columbia Presbyterian Medical Center. Subjects under-
ent a standardized interview and physical examination.
hose with evidence of coronary artery disease by symptoms
r signs, or with hypercholesterolemia (LDL 160 mg/dl),
ypertension (blood pressure [BP] 140/90 mm Hg),
iabetes mellitus (fasting glucose 125 mg/dl), or cigarette
moking were excluded. The study protocol was approved
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May 19, 2004:1828–33 Effect of Lp(a) and apo(a) on Endothelial Functiony the institutional review board, and all participants gave
nformed consent.
p(a) and apo(a) determination. Lipoprotein(a) levels
ere measured by using an enzyme-linked immunoassay
nsensitive to size variation in apo(a) (Sigma Diagnostics,
t. Louis, Missouri). The apo(a) isoform sizes were ana-
yzed by SDS-agarose gel electrophoresis followed by im-
unoblotting (16). Briefly, 12.5 l of plasma was mixed
ith 30 l of sample buffer, and 10 l of the mixture was
oaded on a 2% submarine agarose gel. Samples were
eparated for 15 h at 100 V at 4°C using 45 mM Tris-borate
uffer, pH 8.6, containing 2 mM EDTA. Proteins were
ransferred onto nitrocellulose (Amersham Hybond-C ex-
ra, Arlington Heights, Illinois) using an electroblotter for
h in the cold. The nitrocellulose membrane is blocked
sing powdered skim milk and then incubated with a
rimary antibody against apo(a) (Incstar, Stillwater, Min-
esota). The apo(a) bands were visualized with the ECL
mersham technique on Kodak X-OMAT films using a
econd, labeled antibody (Pierce, Rockford, Illinois). Apo-
ipoprotein(a) size was assigned based on the number of K4
epeats of the quantitatively dominant allele and was con-
idered as “small” or “large” using a cutoff point of 22 K4
epeats (8–10). For heterozygotes with two alleles of equal
ntensity, apo(a) size was assigned to the smaller of the two
soforms. Subjects lacking a detectable allele were excluded.
Table 1. Patient Characteristics
Total
No. of subjects 89
Gender, male/female 50/39
Age, yrs 41.9  9.4
Mean Lp(a), mg/dl 37.0  40.5
Median Lp(a), mg/dl 22.1
IQR Lp(a), mg/dl 40.8
apo(a) number of K4 26.7  5.0
Baseline diameter, cm 0.39  0.08
FMD, % 5.3  4.2
Reactive hyperemia, % 550  160
NTG, % 19.5  8.4
Total cholesterol, mg/dl 177  29
LDL-cholesterol, mg/dl 112  26
HDL-cholesterol, mg/dl 47.3  12.1
Triglycerides, mg/dl 100  75
Systolic blood pressure, mm Hg 115  12
Glucose, mg/dl 78  11
*p  0.01 and †p  0.05 between African Americans and C
apo(a)  apolipoprotein(a); FMD  flow-mediated dilat
Abbreviations and Acronyms
apo(a)  apolipoprotein(a)
FMD  flow-mediated dilation
HDL  high-density lipoprotein
K4  kringle 4
LDL  low-density lipoprotein
Lp(a)  lipoprotein(a)
NTG  nitrate-induced dilationK4  kringle 4; LDL  low-density lipoprotein; Lp(a)  lipoprossessment of vascular function. Endothelial and smooth
uscle function of the brachial arteries were assessed using
10-MHz linear array ultrasound transducer (Agilent 5500,
ndover, Massachusetts). The vessel was imaged above the
ntecubital fossa in the longitudinal plane. Flow-mediated
ilation was measured as the dilator response to reactive
yperemia induced by inflation of a BP cuff to suprasystolic
evel (300 mm Hg) on the forearm for 5 min. End-
iastolic images were acquired every 3 s for 90 s before and
fter cuff deflation. Smooth muscle dilation was tested by
00 g of sublingual nitroglycerin followed by imaging at 3
in after oral absorption. Vascular reactivity was measured
y two observers blinded to the clinical details of the study
ubjects. Arterial diameter was determined using automatic
dge detection software (Information Integrity, Stowe,
assachusetts). Five consecutive diameter measurements
ere taken 60 s after cuff deflation for FMD and 4 min after
itrate-induced dilation (NTG). Values obtained by the two
bservers were averaged and expressed as a percentage
hange in vessel diameter from baseline. The interobserver
ariability for FMD was 2.1% based on a sample of 10
ubjects.
tatistics. The relationship of Lp(a) levels and apo(a) sizes
o vascular function was assessed as dichotomous as well as
ontinuous variables. Differences among ethnic groups for
ontinuous variables were analyzed by analysis of variance
ith post-hoc tests using Tukey’s procedure. Gender dif-
erences were assessed by chi-square analysis. Univariate
nalysis of the effect of each potential risk factor on FMD
nd NTG was first performed by linear regression for age,
ender, LDL-cholesterol, high-density lipoprotein (HDL)
holesterol, logarithmically transformed triglycerides, sys-
olic BP, and fasting glucose levels for each ethnic group.
imilar analysis was also performed for the entire cohort
fter differences in correlation coefficients among ethnic
aucasian African American Hispanic
40 28 21
22/18 16/12 12/9
0  11.4 40.7  5.9 39.5  8.7
3  21.1 68.8  46.0* 30.2  36.5
10.3 55.0 16.5
21.5 71.7 29.8
0  4.8 24.4  4.7† 27.3  4.9
8  0.08 0.41  0.08 0.39  0.08
6  4.3 4.2  4.5 6.2  8.4
3  186 533  133 542  189
4  8.8 20.6  8.7 18.0  7.0
6  34 171  26 189  22
1  29 105  23 121  24
4  12.7 48.6  12.5 47.1  10.8
1  103 84  36 102  43
4  13 118  11 115  12
8  11 77  11 79  12
ians by Tukey’s post-hoc test.
DL  high-density lipoprotein; IQR  interquartile range;C
44.
18.
28.
0.3
5.
58
19.
17
11
46.
11
11
7
aucas
ion; Htein(a); NTG  nitrate-induced dilation.
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Effect of Lp(a) and apo(a) on Endothelial Function May 19, 2004:1828–33roups were tested using Fisher z transform followed by a
ukey-type test of differences in the transformed variables.
he association between FMD and Lp(a) levels and be-
ween FMD and apo(a) sizes adjusted for other risk factors
ere examined using multiple regression. Only variables
hat were significant by univariate analysis were entered into
he multivariate model. To test for differences in the effect
f Lp(a) and apo(a) on FMD among race-ethnic groups,
nteraction terms were added to the multivariate models
sing indicator variables that quantified differences in the
lope terms between Caucasians and African Americans and
etween Caucasians and Hispanics. Analysis of variance was
erformed to jointly test the effect of Lp(a) levels (low vs.
igh) and apo(a) sizes (small vs. large) on FMD and on
TG.
ESULTS
ubjects. A total of 89 subjects (age 42  9 years; 50 men,
9 women) comprised of 40 Caucasians, 28 African Amer-
cans, and 21 Hispanics were recruited (Table 1). All
ubjects had normal lipoprotein profiles, BPs, and fasting
lucose levels. Lipoprotein(a) levels were found to be lowest
n Caucasians, intermediate in Hispanics, and highest in
merican Americans.
orrelation of risk factors with endothelial function.
nivariate analysis within each ethnic group revealed non-
ignificant correlation between FMD and various risk fac-
ors. The correlation coefficient (r) between Lp(a) and
MD was 0.01 among Caucasians, 0.44 among African
mericans, and 0.46 among Hispanics; and for apo(a)
nd FMD, r was 0.30, 0.44, and 0.10, respectively. When
nalysis was performed for the entire cohort, significant
orrelation was found with gender, baseline vessel diameter,
p(a) level, and apo(a) size (Table 2). In this population
ithout known risk factors, total cholesterol, LDL, HDL,
riglycerides, BP, and glucose did not correlate with FMD.
orrelation analysis was also performed with absolute vessel
ilation, which yielded similar results as FMD with signif-
able 2. Univariate Correlation Coefficients for Various Risk
actors and Endothelium-Dependent, Flow-Mediated Dilation
Variables
Correlation
Coefficient p Value
p(a) 0.33 0.002
po(a) 0.34 0.001
ale gender 0.35 0.001
aseline vessel diameter 0.29 0.006
ge 0.13 0.13
ystolic blood pressure 0.08 0.48
otal cholesterol 0.04 0.68
og triglycerides 0.11 0.29
DL 0.11 0.32
DL 0.02 0.85
lucose 0.18 0.10
po(a)  apolipoprotein(a); HDL  high-density lipoprotein; LDL  low-density
ipoprotein; Lp(a)  lipoprotein(a).cance for Lp(a), apo(a), and gender (data not shown). In dddition, neither Lp(a) levels (r  0.06, p  0.55) nor
po(a) sizes (r  0.01, p  0.94) related significantly with
aseline vessel diameter.
As expected, Lp(a) levels correlated with apo(a) sizes in
ur cohort (r0.52, p 0.05). Given the known inverse
elationship between Lp(a) levels and apo(a) sizes, multiple
egression analysis was performed separately for each of
hese factors. In each of these analyses, Lp(a) and apo(a)
ere found to correlate significantly with FMD after ad-
usting for gender (r  0.33, p  0.002, and r  0.34, p
0.001, respectively) (Figs. 1 and 2). (Although baseline
essel diameter correlated with FMD in univariate analysis,
his parameter was not included in the multivariate model
ecause its numerical correlation with FMD may mask
mportant biological associations.) In addition, the relation-
hip of Lp(a) levels to FMD was stronger in African
mericans than in Caucasians (p  0.05). No significant
ifference in this relationship was observed between His-
anics and Caucasians (p  0.31). A similar trend was
bserved for apo(a) on FMD between African Americans
nd Caucasians (p  0.11) but not between Hispanics and
aucasians (p  0.85). No relationship was found between
ither Lp(a) and NTG (r  0.06, p  0.60) or apo(a) and
TG (r  0.13, p  0.25).
nteraction of Lp(a) and apo(a) on endothelial function.
o examine the interaction between Lp(a) and apo(a) on
ndothelial function, subgroup analyses were performed
ith subjects stratified according to a cutoff point of 30
g/dl for Lp(a) level and 22 K4 repeats for apo(a) size.
ubjects with high Lp(a) levels were found to have signif-
cantly lower degree of FMD than those with low Lp(a)
evels (3.90 3.58% vs. 6.22 4.47%, p 0.01). Similarly,
hose with 22 K4 repeats had significantly lower FMD
han subjects with 22 K4 (2.23  2.37% vs. 6.26 
.29%, p  0.0001). Analysis of variance was then per-
ormed with subjects who were divided into four groups
ased on both Lp(a) level and apo(a) size (Fig. 3). Flow-
ediated dilation was relatively preserved with apo(a) sizes
22 K4 (groups A and B), even when they were associated
ith high Lp(a) levels (group B). When apo(a) sizes were
22 K4, FMD was markedly reduced (groups C and D),
espite having Lp(a) levels that were low (group C). The
po(a) size effect was statistically significant (p  0.001).
imilar analyses were performed for NTG, but no differ-
nces were found between subjects with high and low Lp(a)
18.97  7.65% vs. 19.80  7.55%, p  0.05) or between
ubjects with small and large apo(a) (18.65  8.98% vs.
9.96  8.29%, p  0.54).
ISCUSSION
he present study found high levels of Lp(a) to be inde-
endently associated with impaired endothelial function in a
ultiethnic cohort. Because of inconsistencies in epidemi-
logic data, the independent role of Lp(a) in cardiovascular
isease has been questioned. One possible explanation of
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May 19, 2004:1828–33 Effect of Lp(a) and apo(a) on Endothelial Functionp(a)’s link to atherosclerosis is through its potentiation of
ther risk factors, such as LDL cholesterol. By excluding
ubjects with established cardiac risk factors, we were able to
emonstrate a significant independent effect of Lp(a) on
ndothelial function. The effect of Lp(a) was found to be
odest in degree with each 10 mg/dl increment in levels
ccounting for only 0.4% decrement in FMD. However,
ecause the study cohort was relatively young, the observed
agnitude may not be truly reflective of the effect of Lp(a).
igure 1. Scatterplot of lipoprotein(a), or Lp(a), levels and flow-mediated
aucasians; solid squares  African Americans; open triangles  Hispa
igure 2. Scatterplot of apolipoprotein(a), or apo(a), sizes and flow-media
mericans; open triangles  Hispanics.t remains possible that the effect of Lp(a) might be further
mplified through interaction with other risk factors.
The results of this study add to the sum of evidence that
ndicates that high levels of Lp(a) are associated with
reclinical markers of atherosclerotic disease. Previously,
everal studies have found Lp(a) to be related to early
tructural changes of the carotid arteries as measured by
ntima-media thickness (10,17,18). The present study ex-
ends these abnormalities to include a functional defect of
ion (FMD) showing a significant inverse correlation. Open diamonds 
r  0.33; p  0.005.
ilation (FMD). Open diamonds  Caucasians; solid squares  Africandilatted d
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Effect of Lp(a) and apo(a) on Endothelial Function May 19, 2004:1828–33he vasculature related to Lp(a). These observations seem to
iffer from those recently reported by Raitakari et al. (19).
sing similar methodology, these investigators found Lp(a)
evels not to correlate with either FMD or with carotid
ntimal-medial disease. An in-depth comparison of the two
tudies is revealing. In contrast with our multiethnic cohort,
he latter study was comprised exclusively of Caucasian
ubjects whose Lp(a) levels were comparatively low (mean
f 18.3 vs. 38.7 mg/dl). In our study, significant impairment
n FMD was observed only at Lp(a) levels well above 30
g/dl (Fig. 1). Only a small percentage of subjects (19%) in
he Raitakari et al. (19) study have Lp(a) above this level in
ontrast with 39% of our subjects. Furthermore, the major-
ty of our subjects (80%) with Lp(a) levels above 30 g/dl
ere of non-Caucasian descent, of whom 63% were African
mericans and 17% were Hispanics. Thus, the relationship
etween Lp(a) and FMD was evident in our study because
on-Caucasian subjects were included in the overall analy-
is. Indeed, on closer examination, the data on Caucasian
ubjects was remarkably similar in the two studies. These
esults suggest that the paradox of a lack of disease associ-
tion with Lp(a) levels in African Americans may be
xplained by methodological factors rather than on mecha-
istic grounds.
Apart from Lp(a) levels, apo(a) sizes were also found to
ave a significant negative effect on endothelial function. As
hown in Figure 3, the presence of just one predominant
soform of small apo(a) was associated with markedly
educed FMD. This effect holds true even when the
orresponding Lp(a) levels were low (group C). Thus, our
nalysis revealed that consideration of apo(a) size enhances
he ability to predict impaired endothelial function. The
odest difference in FMD between subjects with low and
igh Lp(a) levels was magnified when apo(a) sizes were
onsidered (Fig. 3) (group A vs. C and group B vs. D). The
pproach of taking into account apo(a) size in risk stratifi-
igure 3. Endothelium-dependent flow-mediated dilation (FMD) accord-
ng to four categories based on low and high lipoprotein(a), or Lp(a), levels
cutoff, 30 mg/dl) with small and large apolipoprotein(a), or apo(a), sizes
cutoff, 22 kringle 4 repeats). n indicates number of subjects in each
ategory. *p  0.001 between small and large apo(a) size groups.ation may be especially important in African Americans in
hom Lp(a) levels correlate less closely with apo(a) sizes
11,12).
Our results pointing to a proatherogenic potential of
po(a) is supported by recent experimental evidence. The
po(a) components have been shown to be critical in the
nitiation of atherogenesis via induction of chemotactic
ctivity to circulating monocytes (20,21), enhancement of
xpression of intercellular adhesion molecule-1 (22), and
romotion of lipid uptake by macrophages (23). Thus, in
ddition to its effect on Lp(a) level, apo(a) itself appears to
xert direct effects on atherogenesis. Although small apo(a)
izes have previously been shown to enhance prothrombotic
otential of Lp(a) (24,25), our study substantiates in vivo
hat apo(a) size variation may confer atherogenic properties
26). Further studies are needed to delineate the precise
echanism by which apo(a) size heterogeneity predispose to
therosclerosis.
This study has several limitations. Although a negative
orrelation between Lp(a) and FMD was observed across all
thnic groups, we lacked the power to demonstrate statis-
ical significance within each group. Further studies in larger
opulations are needed to address this point. Another
imitation relates to the uncertain prognostic significance of
mpaired endothelial function of the peripheral circulation
s a predictor of adverse cardiovascular outcome. Although
ndothelial dysfunction of the coronary circulation has been
hown to be predictive of adverse cardiac events, the effect of
eripheral endothelial dysfunction has yet been conclusively
emonstrated. Nevertheless, impaired endothelial function
n the brachial artery has been shown to be reflective of the
unctional state of the coronary endothelium (27) and to
orrelate with the extent and severity of coronary athero-
clerosis (28). Finally, the cross-sectional nature of this
tudy precludes definitive demonstration of a causal rela-
ionship between Lp(a) and endothelial dysfunction. Be-
ause apo(a) phenotype and Lp(a) level are both under
enetic control, their association with endothelial dysfunc-
ion is likely primary in nature rather than secondary to
ubclinical disease.
In conclusion, the present study supports an independent
ole of Lp(a) in atherogenesis, an effect that is not limited to
aucasians but is particularly evident in African Americans.
n addition, consideration of apo(a) size will likely refine our
bility to assess an individual’s cardiovascular risk. Together,
hese findings give impetus to conducting large-scale pro-
pective studies to evaluate the risk associated with both
p(a) levels and apo(a) sizes in different ethnic populations.
eprint requests and correspondence: Dr. Henry D. Wu, Di-
ision of Cardiology, Columbia University, 630 West 168th Street
PH342), New York, New York 10032. E-mail: hdw1@
olumbia.edu.
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